Expert guideline survey for prostate cancer care
Part of Blood & lymphatic, Cancer clinical trials.
This study uses a structured expert survey to help build clear, agreed-upon guidelines for prostate cancer care. If you’re a board-certified clinician who actively treats prostate cancer, your input can help shape how care is recommended.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 21 or older
- Be board-certified in Radiation Oncology, Radiation Physics, Urology, and/or Medical Oncology
- Currently practice actively and see patients with prostate cancer
- Be able to speak and respond in English
- Understand you must be able to consent to take part (not a prisoner or otherwise unable to consent)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an educational program to help patients with advanced cancer talk about their goals of care. The goal is to make sure your wishes are known and respected by your care team.
This study tests whether a structured health education and “older adult care” approach—done with your oncology team—can improve support for people after cancer. It includes older cancer survivors and a chosen caregiver, using in-person or video visits for follow-up.
This study talks with older adults, their caregivers, and healthcare providers to learn what help and support older patients need before starting cancer treatment. The goal is to better understand these needs so clinics can offer the right support.
This trial tests an English decision aid (a patient guide) to help older men understand and feel comfortable with “active surveillance” for localized prostate cancer. It also checks how easy to use it is for patients, caregivers, and prostate cancer clinicians.
This study tests a digital tool called MyCareGorithm that helps patients understand their cancer treatment plans. It is for people with head and neck or prostate cancer, their caregivers, and their doctors.
This study tests a new assessment system (a set of questions/tools) to better measure how much distress cancer patients feel from symptoms. It may help cancer teams better understand your symptom burden and improve support.
Hear when a new Hematopoietic and Lymphoid Cell Neoplasm trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.